Acadia Pharmaceuticals announced two new appointments to its executive team. Jennifer Rhodes is joining the company as executive VP, chief legal officer and secretary, and Kimberly Manhard as senior VP, global strategic planning and execution, both effective immediately. Following a transition period, Austin Kim, executive VP, general counsel and secretary will be leaving Acadia to pursue other opportunities.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ACAD:
- Acadia Pharmaceuticals initiated with an Outperform at Baird
- Needham upgraades Acadia Pharmaceuticals to Buy on positive survey data
- Acadia Pharmaceuticals upgraded to Buy from Hold at Needham
- Acadia Pharmaceuticals price target raised to $40 from $35 at Mizuho
- ‘Time to Pull the Trigger,’ Says Morgan Stanley About These 2 Healthcare Stocks
